Prostate Cancer Reports
54

Volume 5 Number 10
October 2017


Home > Prostate Cancer Reports > Volume 5, Year 2017 > Number 10, October



CONTENTS



DIAGNOSIS
EPIDEMIOLOGY, RISK FACTORS, PREVENTION
FOLLOW-UP, QUALITY OF LIFE
INTEGRATIVE MEDICINE
OVERALL MANAGEMENT
PROGNOSIS
TREATMENT





DIAGNOSIS



Bailey J, Piert M.
Performance of 68Ga-PSMA PET/CT for Prostate Cancer Management at Initial Staging and Time of Biochemical Recurrence.
Curr Urol Rep. 2017 Sep 9;18(11):84. doi: 10.1007/s11934-017-0736-1.
Source | Abstract | Full text | Similar articles




Boesen L, Nørgaard N, Løgager V, Balslev I, Thomsen HS.
Where Do TRUS- and MRI Guided Biopsies Miss Significant Prostate Cancer?
Urology. 2017 Aug 30. pii: S0090-4295(17)30899-3. doi: 10.1016/j.urology.2017.08.028. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Couñago F, Sancho G, Catalá V, Hernández D, Recio M, Montemuiño S, Hernández JA, Maldonado A, Del Cerro E.
Magnetic resonance imaging for prostate cancer before radical and salvage radiotherapy: What radiation oncologists need to know.
World J Clin Oncol. 2017 Aug 10;8(4):305-319. doi: 10.5306/wjco.v8.i4.305.
Source | Abstract | Full text | Similar articles




Kitajima K, Fukushima K, Yamamoto S, Kato T, Odawara S, Takaki H, Fujiwara M, Yamakado K, Nakanishi Y, Kanematsu A, Nojima M, Hirota S.
Diagnostic performance of 11C-choline PET/CT and bone scintigraphy in the detection of bone metastases in patients with prostate cancer.
Nagoya J Med Sci. 2017 Aug;79(3):387-399. doi: 10.18999/nagjms.79.3.387.
Source | Abstract | Full text | Similar articles




Mena E, Lindenberg ML, Shih JH, Adler S, Harmon S, Bergvall E, Citrin D, Dahut W, Ton AT, McKinney Y, Weaver J, Eclarinal P, Forest A, Afari G, Bhattacharyya S, Mease RC, Merino MJ, Pinto P, Wood BJ, Jacobs P, Pomper MG, Choyke PL, Turkbey B.
Clinical impact of PSMA-based 18F-DCFBC PET/CT imaging in patients with biochemically recurrent prostate cancer after primary local therapy.
Eur J Nucl Med Mol Imaging. 2017 Sep 11. doi: 10.1007/s00259-017-3818-x. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Sanli Y, Kuyumcu S, Sanli O, Buyukkaya F, İribaş A, Alcin G, Darendeliler E, Ozluk Y, Yildiz SO, Turkmen C.
Relationships between serum PSA levels, Gleason scores and results of 68Ga-PSMAPET/CT in patients with recurrent prostate cancer.
Ann Nucl Med. 2017 Sep 12. doi: 10.1007/s12149-017-1207-y. [Epub ahead of print]
Source | Abstract | Full text | Similar articles





EPIDEMIOLOGY, RISK FACTORS, PREVENTION



Xia J, Chen J, Xue JX, Yang J, Wang ZJ.
An Up-to-date Meta-analysis of Coffee Consumption and Risk of Prostate Cancer.
Urol J. 2017 Aug 29;14(5):4079-4088.
Source | Abstract | Full text | Similar articles





FOLLOW-UP, QUALITY OF LIFE



Nyarangi-Dix JN, Steimer J, Bruckner T, Jakobi H, Koerber SA, Hadaschik B, Debus J, Hohenfellner M.
Post-prostatectomy radiotherapy adversely affects urinary continence irrespective of radiotherapy regime.
World J Urol. 2017 Aug 31. doi: 10.1007/s00345-017-2081-x. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Pompe RS, Tian Z, Preisser F, Tennstedt P, Beyer B, Michl U, Graefen M, Huland H, Karakiewicz PI, Tilki D.
Short- and Long-term Functional Outcomes and Quality of Life after Radical Prostatectomy: Patient-reported Outcomes from a Tertiary High-volume Center.
Eur Urol Focus. 2017 Aug 28. pii: S2405-4569(17)30193-1. doi: 10.1016/j.euf.2017.08.001. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Smith ZL, Eggener SE.
In localised prostate cancer, radical prostatectomy was associated with more sexual dysfunction and urinary incontinence than radiation or active surveillance.
Evid Based Med. 2017 Aug 16. pii: ebmed-2017-110772. doi: 10.1136/ebmed-2017-110772. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Tsikis ST, Nottingham CU, Faris SF.
The Relationship Between Incontinence and Erectile Dysfunction After Robotic Prostatectomy: Are They Mutually Exclusive?
J Sex Med. 2017 Sep 2. pii: S1743-6095(17)31353-X. doi: 10.1016/j.jsxm.2017.08.002. [Epub ahead of print]
Source | Abstract | Full text | Similar articles





INTEGRATIVE MEDICINE



Capurso C, Vendemiale G.
The Mediterranean Diet Reduces the Risk and Mortality of the Prostate Cancer: A Narrative Review.
Front Nutr. 2017 Aug 24;4:38. doi: 10.3389/fnut.2017.00038. eCollection 2017.
Source | Abstract | Full text | Similar articles




Melnik BC.
Milk disrupts p53 and DNMT1, the guardians of the genome: implications for acne vulgaris and prostate cancer.
Nutr Metab (Lond). 2017 Aug 15;14:55. doi: 10.1186/s12986-017-0212-4. eCollection 2017.
Source | Abstract | Full text | Similar articles




Mucci LA, Kantoff PW.
Is the Evidence Sufficient to Recommend Statins for All Men With Prostate Cancer?
J Clin Oncol. 2017 Aug 17:JCO2017747915. doi: 10.1200/JCO.2017.74.7915. [Epub ahead of print]
Comment on: Larsen SB et al. (2017), Postdiagnosis Statin Use and Mortality in Danish Patients With Prostate Cancer.
Source | Abstract | Full text | Similar articles




Thoma C.
Prostate cancer: Postdiagnosis statin use reduces mortality.
Nat Rev Urol. 2017 Aug 31. doi: 10.1038/nrurol.2017.146. [Epub ahead of print]
Comment on: Larsen SB et al. (2017), Postdiagnosis Statin Use and Mortality in Danish Patients With Prostate Cancer.
Source | Abstract | Full text | Similar articles





OVERALL MANAGEMENT



Baker SG.
Validity of Surrogate End Points for Prostate Cancer.
JAMA Oncol. 2017 Aug 31. doi: 10.1001/jamaoncol.2017.0334. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Bartkowiak D, Thamm R, Bottke D, Siegmann A, Böhmer D, Budach V, Wiegel T.
Prostate-specific antigen after salvage radiotherapy for postprostatectomy biochemical recurrence predicts long-term outcome including overall survival.
Acta Oncol. 2017 Aug 17:1-6. doi: 10.1080/0284186X.2017.1364869. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




[No authors listed]
Abstracts of the 18th Asia-Pacific Prostate Cancer Conference 2017, Australia, 30 August-02 September 2017.
BJU Int. 2017 Aug;120 Suppl 1:5-23. doi: 10.1111/bju.13941.
Source | Abstract | Full text | Similar articles




Royce TJ, Chen MH, D'Amico AV.
Validity of Surrogate End Points for Prostate Cancer-Reply.
JAMA Oncol. 2017 Aug 31. doi: 10.1001/jamaoncol.2017.2506. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Royce TJ, Chen MH, Wu J, Loffredo M, Renshaw AA, Kantoff PW, D'Amico AV.
Surrogate End Points for All-Cause Mortality in Men With Localized Unfavorable-Risk Prostate Cancer Treated With Radiation Therapy vs Radiation Therapy Plus Androgen Deprivation Therapy: A Secondary Analysis of a Randomized Clinical Trial.
JAMA Oncol. 2017 May 1;3(5):652-658. doi: 10.1001/jamaoncol.2016.5983.
Source | Abstract | Full text | Similar articles





PROGNOSIS



Aas K, Axcrona K, Kvåle R, Møller B, Myklebust TÅ, Axcrona U, Fosså SD.
10-Year Mortality in Men with Non-Metastatic Prostate Cancer in Norway.
Urology. 2017 Aug 17. pii: S0090-4295(17)30860-9. doi: 10.1016/j.urology.2017.07.048. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Albitar M, Ma W, Lund L, Shahbaba B, Uchio E, Feddersen S, Moylan D, Wojno K, Shore N.
A Multi-Center Prospective Study to Validate an Algorithm Using Urine and Plasma Biomarkers for Predicting Gleason ≥3+4 Prostate Cancer on Biopsy.
J Cancer. 2017 Aug 2;8(13):2554-2560. doi: 10.7150/jca.20031. eCollection 2017.
Source | Abstract | Full text | Similar articles




Dwivedi DK, Kumar R, Dwivedi AK, Bora GS, Thulkar S, Sharma S, Gupta SD, Jagannathan NR.
Prebiopsy multiparametric MRI-based risk score for predicting prostate cancer in biopsy-naive men with prostate-specific antigen between 4-10 ng/mL.
J Magn Reson Imaging. 2017 Sep 4. doi: 10.1002/jmri.25850. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Lee H, Lee IJ, Byun SS, Lee SE, Hong SK.
Favorable Gleason 3 + 4 Prostate Cancer Shows Comparable Outcomes With Gleason 3 + 3 Prostate Cancer: Implications for the Expansion of Selection Criteria for Active Surveillance.
Clin Genitourin Cancer. 2017 Aug 2. pii: S1558-7673(17)30230-6. doi: 10.1016/j.clgc.2017.07.020. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Marsh S, Walters RW, Silberstein PT.
Survival Outcomes of Radical Prostatectomy Versus Radiotherapy in Intermediate-Risk Prostate Cancer: A NCDB Study.
Clin Genitourin Cancer. 2017 Aug 8. pii: S1558-7673(17)30239-2. doi: 10.1016/j.clgc.2017.07.029. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Porcaro AB, Siracusano S, de Luyk N, Corsi P, Sebben M, Tafuri A, Mattevi D, Bizzotto L, Tamanini I, Cerruto MA, Martignoni G, Brunelli M, Artibani W.
Low-Risk Prostate Cancer and Tumor Upgrading in the Surgical Specimen: Analysis of Clinical Factors Predicting Tumor Upgrading in a Contemporary Series of Patients Who were Evaluated According to the Modified Gleason Score Grading System.
Curr Urol. 2017 Aug;10(3):118-125. doi: 10.1159/000447164. Epub 2017 Jul 30.
Source | Abstract | Full text | Similar articles




Rodin D, Drumm M, Clayman R, Buscariollo DL, Galland-Girodet S, Eidelman A, Feldman AS, Dahl DM, McGovern FJ, Olumi AF, Niemierko A, Shipley WU, Zietman AL, Efstathiou JA.
Risk Factors for Disease Progression After Postprostatectomy Salvage Radiation: Long-term Results of a Single-institution Experience.
Clin Genitourin Cancer. 2017 Aug 3. pii: S1558-7673(17)30236-7. doi: 10.1016/j.clgc.2017.07.026. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Susperregui J, Pierry C, Bonhomme B, Pasticier G, Bernhard JC, Capon G, Bensadoun H, Ballanger P, Ferrière JM, Robert G.
Influence du score de Gleason des marges chirurgicales de prostatectomie totale sur la récidive biologique.
Prog Urol. 2017 Oct;27(12):632-639. doi: 10.1016/j.purol.2017.07.239. Epub 2017 Aug 30. French.
Source | Abstract | Full text | Similar articles




Teeter AE, Griffin K, Howard LE, Aronson WJ, Terris MK, Kane CJ, Amling CL, Cooperberg MR, Freedland SJ.
Does early PSADT (ePSADT) after Radical Prostatectomy, Calculated prior to PSA Recurrence, Correlate with Prostate Cancer Outcomes? -A Report from the SEARCH Database Group.
J Urol. 2017 Sep 1. pii: S0022-5347(17)77427-7. doi: 10.1016/j.juro.2017.08.107. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Thoma C.
Prostate cancer: Stratifying salvage radiotherapy utility.
Nat Rev Urol. 2017 Aug 31. doi: 10.1038/nrurol.2017.145. [Epub ahead of print]
Comment on: Fossati N et al. (2017), Impact of Early Salvage Radiation Therapy in Patients with Persistently Elevated or Rising Prostate-specific Antigen After Radical Prostatectomy.
Source | Abstract | Full text | Similar articles





TREATMENT



Kim J, Park JS, Ham WS.
The role of metastasis-directed therapy and local therapy of the primary tumor in the management of oligometastatic prostate cancer.
Investig Clin Urol. 2017 Sep;58(5):307-316. doi: 10.4111/icu.2017.58.5.307. Epub 2017 Aug 8.
Source | Abstract | Full text | Similar articles